<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0215">
 <label>43</label>
 <element-citation publication-type="journal" id="sbref0215">
  <person-group person-group-type="author">
   <name>
    <surname>Schroeder</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Khoury</surname>
    <given-names>H.J.</given-names>
   </name>
   <name>
    <surname>Jagasia</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ali</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Schiller</surname>
    <given-names>G.J.</given-names>
   </name>
  </person-group>
  <article-title>A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease</article-title>
  <source>Blood Adv.</source>
  <volume>28</volume>
  <issue>8</issue>
  <year>2020</year>
  <fpage>1656</fpage>
  <lpage>1669</lpage>
  <pub-id pub-id-type="doi">10.1182/bloodadvances.2019001043</pub-id>
  <comment>(2020)</comment>
 </element-citation>
</ref>
